10x Science

10x Science is a Y Combinator-backed company that the AI-native platform for next-generation protein characterization. Based in San Francisco, USA, the company participated in the Winter 2026 batch of Y Combinator.

10x Science develops frontier AI models with deep memory to redefine how scientists understand and engineer biology across the life sciences, starting with drug development.

AI-powered drug discovery is flooding the pipeline with new candidates faster than ever. But before any of them can advance to the clinic, scientists must deeply characterize the protein therapeutic to understand whether it will work.

10x Science was part of Y Combinator's Winter 2026 cohort, has a team of approximately 3 employees, and is actively operating.